Julie Teruya-Feldstein, MD


Director, Hematopathology; Director, Immunohistochemistry Laboratory

Conditions Treated:

Julie Teruya-Feldstein, MD -- Director, Hematopathology; Director, Immunohistochemistry Laboratory

About Me

I am a board-certified pathologist and director of Memorial Sloan Kettering’s Immunohistochemistry Laboratory. I examine tissue and blood samples and help diagnose and stage hematologic cancers including leukemia, lymphoma, myeloma, and other blood diseases.

Read more

I am involved in a number of research studies designed to improve treatments for patients with these diseases using targeted therapies and stem cell transplants, and have contributed to more than 100 published studies in this area. I am also a member of Memorial Sloan Kettering’s Institutional Review Board and help determine which clinical trials doctors at the Center will participate in.

I have lectured nationally and internationally on advances in hematopathology.

  • Clinical Expertise: Hematopathology
  • Languages Spoken: English
  • Education: MD, University of Hawaii
  • Residencies: National Cancer Institute
  • Fellowships: National Cancer Institute
  • Board Certifications: Anatomic Pathology

New Patient Appointments

Making an appointment

Call 800-525-2225


Visit PubMed for a full listing of Julie Teruya-Feldstein’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.

Learn more